🔴 Solid Biosciences is trading 5.1% down today amid broader biotech sector weakness

Solid Biosciences is trading at $9.13 (down 5.1%) as risk-off sentiment impacts growth stocks and the broader biotech sector.

• The move occurs on above-average intraday volatility despite a lack of fresh company-specific headlines, analyst calls, or regulatory updates.
• The decline follows several recent down days for the stock, suggesting the move is driven by broader market caution rather than a new, stock-specific shock.